全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

CD4+T淋巴细胞在侵袭性肺部真菌感染的研究进展
Research Progress of CD4+T Lymphocytes in Invasive Pulmonary Fungal Infection

DOI: 10.12677/ACM.2023.134921, PP. 6572-6576

Keywords: CD4+T淋巴细胞,侵袭性真菌病,侵袭性肺部真菌感染
CD4+T Lymphocytes
, Invasive Mycosis, Invasive Pulmonary Fungal Infection

Full-Text   Cite this paper   Add to My Lib

Abstract:

威胁生命的侵袭性肺部真菌感染(Invasive pulmonary fungal infection)的发病率正在增加,特别是在免疫功能低下的患者中,成功解决IFD需要多种不同的免疫细胞参与。本文主要综述了人类CD4+T淋巴细胞对IFD主要病原体的免疫反应的证据,以及淋巴细胞群在抗真菌免疫中作用的最新发现和见解,以加深淋巴细胞在抗真菌中作用机制的理解,为改进抗真菌治疗提供新的思路。
The incidence rate of life threatening invasive pulmonary fungal infection is increasing, especially in patients with low immune function. A variety of different immune cells are needed to successfully solve IFD. This article mainly reviews the evidence of the immune response of human CD4+T lym-phocytes to the main pathogens of IFD, as well as the latest findings and insights on the role of lym-phocyte groups in antifungal immunity, in order to deepen the understanding of the mechanism of lymphocytes in antifungal immunity, and provide new ideas for improving antifungal therapy.

References

[1]  (2020) The Chinese Guidelines for the Diagnosis and Treatment of Invasive Fungal Disease in Patients with Hematolog-ical Disorders and Cancers (the 6th Revision). Chinese Journal of Internal Medicine, 59, 754-763.
[2]  Brown, G.D., Denning, D.W., Gow, N.A., et al. (2012) Hidden Killers: Human Fungal Infections. Science Translational Medicine, 4, 165rv13.
https://doi.org/10.1126/scitranslmed.3004404
[3]  Ye, F., Xie, J.X., Zeng, Q.S., et al. (2012) Retrospec-tive Analysis of 76 Immunocompetent Patients with Primary Pulmonary Cryptococcosis. Lung, 190, 339-346.
https://doi.org/10.1007/s00408-011-9362-8
[4]  Hsu, L.Y., Lee, D.G., Yeh, S.P., et al. (2015) Epidemiology of Invasive Fungal Diseases among Patients with Haematological Disorders in the Asia-Pacific: A Prospective Observa-tional Study. Clinical Microbiology and Infection, 21, 594.e7-11.
https://doi.org/10.1016/j.cmi.2015.02.019
[5]  Valentine, J.C., Morrissey, C.O., Tacey, M.A., et al. (2020) A Pop-ulation-Based Analysis of Attributable Hospitalisation Costs of Invasive Fungal Diseases in Haematological Malignancy Patients Using Data Linkage of State-Wide Registry and Costing Databases: 2009-2015. Mycoses, 63, 162-171.
https://doi.org/10.1111/myc.13033
[6]  Jeong, W., Keighley, C., Wolfe, R., et al. (2019) The Epidemiology and Clinical Manifestations of Mucormycosis: A Systematic Review and Meta-Analysis of Case Reports. Clinical Microbi-ology and Infection, 25, 26-34.
https://doi.org/10.1016/j.cmi.2018.07.011
[7]  Liao, Y., Chen, M., Hartmann, T., et al. (2013) Epidemiology of Opportunistic Invasive Fungal Infections in China: Review of Literature. Chinese Medical Journal, 126, 361-368.
[8]  Lionakis, M.S. and Levitz, S.M. (2018) Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts. Annual Review of Immunology, 36, 157-191.
https://doi.org/10.1146/annurev-immunol-042617-053318
[9]  Gao, Y. and Soubani, A. (2019) Advances in the Diagnosis and Management of Pulmonary Aspergillosis. Advances in Respiratory Medicine, 87, 231-243.
https://doi.org/10.5603/ARM.2019.0061
[10]  Wald, A., Leisenring, W., Van Burik, J.A., et al. (1997) Epidemiol-ogy of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation. The Journal of Infectious Diseases, 175, 1459-1466.
https://doi.org/10.1086/516480
[11]  Kontoyiannis, D.P. and Bodey, G.P. (2002) Invasive Aspergillosis in 2002: An Update. European Journal of Clinical Microbiology & Infectious Diseases, 21, 161-172.
https://doi.org/10.1007/s10096-002-0699-z
[12]  Marr, K.A., Carter, R.A., Crippa, F., et al. (2002) Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients. Clinical Infectious Diseases, 34, 909-917.
https://doi.org/10.1086/339202
[13]  Kaur, R., Dhakad, M.S., Goyal, R., et al. (2016) Spectrum of Op-portunistic Fungal Infections in HIV/AIDS Patients in Tertiary Care Hospital in India. Canadian Journal of Infectious Diseases and Medical Microbiology, 2016, Article ID: 2373424.
https://doi.org/10.1155/2016/2373424
[14]  Benito, N., Moreno, A., Miro, J.M., et al. (2012) Pulmonary Infections in HIV-Infected Patients: An Update in the 21st Century. European Respiratory Journal, 39, 730-745.
https://doi.org/10.1183/09031936.00200210
[15]  Van de Veerdonk, F.L. and Netea, M.G. (2010) T-Cell Subsets and Antifungal Host Defenses. Current Fungal Infection Reports, 4, 238-243.
https://doi.org/10.1007/s12281-010-0034-6
[16]  Speakman, E.A., Dambuza, I.M., Salazar, F., et al. (2020) T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors. Trends in Immunology, 41, 61-76.
https://doi.org/10.1016/j.it.2019.11.007
[17]  Verma, A., Wüthrich, M., Deepe, G., et al. (2014) Adaptive Immunity to Fungi. Cold Spring Harbor Perspectives in Medicine, 5, a019612.
https://doi.org/10.1101/cshperspect.a019612
[18]  Schmidt, S., Tramsen, L. and Lehrnbecher, T. (2017) Natural Killer Cells in Antifungal Immunity. Frontiers in Immunology, 8, 1623.
https://doi.org/10.3389/fimmu.2017.01623
[19]  Mcdermott, A.J. and Klein, B.S. (2018) Helper T-Cell Responses and Pulmonary Fungal Infections. Immunology, 155, 155-163.
https://doi.org/10.1111/imm.12953
[20]  Dewi, I.M.W., Van de Veerdonk, F.L. and Gresnigt, M.S. (2017) The Multifaceted Role of T-Helper Responses in Host De-fense against Aspergillus fumigatus. Journal of Fungi (Basel), 3, 55.
https://doi.org/10.3390/jof3040055
[21]  Bozza, S., Perruccio, K., Montagnoli, C., et al. (2003) A Dendritic Cell Vaccine against Invasive Aspergillosis in Allogeneic Hematopoietic Transplantation. Blood, 102, 3807-3814.
https://doi.org/10.1182/blood-2003-03-0748
[22]  Cenci, E., Mencacci, A., Bacci, A., et al. (2000) T Cell Vaccina-tion in Mice with Invasive Pulmonary Aspergillosis. The Journal of Immunology, 165, 381-388.
https://doi.org/10.4049/jimmunol.165.1.381
[23]  Lin, J.S. and Wu-Hsieh, B.A. (2004) Functional T Cells in Pri-mary Immune Response to Histoplasmosis. International Immunology, 16, 1663-1673.
https://doi.org/10.1093/intimm/dxh168
[24]  Sparber, F. and Leibundgut-Landmann, S. (2019) Interleukin-17 in Antifungal Immunity. Pathogens, 8, 54.
https://doi.org/10.3390/pathogens8020054
[25]  Chai, L.Y., Van De Veerdonk, F., Marijnissen, R.J., et al. (2010) Anti-Aspergillus Human Host Defence Relies on Type 1 T Helper (Th1), Rather than Type 17 T Helper (Th17), Cellular Immunity. Immunology, 130, 46-54.
https://doi.org/10.1111/j.1365-2567.2009.03211.x
[26]  Curtis, M.M. and Way, S.S. (2009) Interleukin-17 in Host Defence against Bacterial, Mycobacterial and Fungal Pathogens. Immunology, 126, 177-185.
https://doi.org/10.1111/j.1365-2567.2008.03017.x
[27]  De Beaucoudrey, L., Samarina, A., Bustamante, J., et al. (2010) Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients from 30 Countries. Medicine, 89, 381-402.
https://doi.org/10.1097/MD.0b013e3181fdd832
[28]  Cypowyj, S., Picard, C., Maródi, L., et al. (2012) Immunity to Infection in IL-17-Deficient Mice and Humans. European Journal of Immunology, 42, 2246-2254.
https://doi.org/10.1002/eji.201242605
[29]  Wiederhold, N.P. (2017) Antifungal Resistance: Current Trends and Future Strategies to Combat. Infection and Drug Resistance, 10, 249-259.
https://doi.org/10.2147/IDR.S124918
[30]  Kumaresan, P.R., Da Silva, T.A. and Kontoyiannis, D.P. (2017) Meth-ods of Controlling Invasive Fungal Infections Using CD8+ T Cells. Frontiers in Immunology, 8, 1939.
https://doi.org/10.3389/fimmu.2017.01939
[31]  Lauruschkat, C.D., Einsele, H. and Loeffler, J. (2018) Immuno-modulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives. Journal of Fungi (Basel), 4, 137.
https://doi.org/10.3390/jof4040137
[32]  Jolink, H., De Boer, R., Hombrink, P., et al. (2017) Pulmonary Im-mune Responses against Aspergillus fumigatus Are Characterized by High Frequencies of IL-17 Producing T-Cells. Journal of Infection, 74, 81-88.
https://doi.org/10.1016/j.jinf.2016.10.010

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133